(-)-anisomycin multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 Anisomycin inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:16038797 (1->4)-beta-D-glucan multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP26A1 mRNA CTD PMID:36331819 (S)-nicotine decreases expression ISO CYP26A1 (Homo sapiens) 6480464 Nicotine results in decreased expression of CYP26A1 mRNA and Nicotine results in decreased expression of CYP26A1 protein CTD PMID:21371177 1,2-dichloroethane increases expression ISO Cyp26a1 (Mus musculus) 6480464 ethylene dichloride results in increased expression of CYP26A1 mRNA CTD PMID:28189721 and PMID:28960355 1-naphthyl isothiocyanate decreases expression EXP 6480464 1-Naphthylisothiocyanate results in decreased expression of CYP26A1 mRNA CTD PMID:25380136 17beta-estradiol multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CYP26A1 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA CTD PMID:17404688 and PMID:20660070 17beta-estradiol decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Estradiol results in decreased expression of CYP26A1 mRNA CTD PMID:26879975 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP26A1 mRNA CTD PMID:32741896 17beta-estradiol multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Promegestone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA CTD PMID:16955405 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP26A1 mRNA CTD PMID:32741896 17beta-hydroxy-5alpha-androstan-3-one multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [Retinaldehyde co-treated with Dihydrotestosterone] results in increased expression of CYP26A1 mRNA CTD PMID:17526768 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO Cyp26a1 (Mus musculus) 6480464 2 more ... CTD PMID:31449830 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [retinol acetate co-treated with 2 more ... CTD PMID:31449830 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO CYP26A1 (Homo sapiens) 6480464 2 more ... CTD PMID:31173147 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CYP26A1 mRNA CTD PMID:19770486 more ... 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CYP26A1 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin affects the methylation of CYP26A1 intron] which results in increased expression of CYP26A1 mRNA and Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to CYP26A1 gene] CTD PMID:28213091 and PMID:33017471 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Cyp26a1 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CYP26A1 mRNA CTD PMID:28922406 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of CYP26A1 mRNA CTD PMID:21346803 2,6-dimethyl-4-tridecylmorpholine affects expression ISO Cyp26a1 (Mus musculus) 6480464 tridemorph affects the expression of CYP26A1 mRNA CTD PMID:34737147 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of CYP26A1 mRNA CTD PMID:21346803 2-Ethylhexanoic acid decreases expression ISO Cyp26a1 (Mus musculus) 6480464 2-ethylhexanoic acid results in decreased expression of CYP26A1 mRNA CTD PMID:30578912 3,3',5,5'-tetrabromobisphenol A decreases expression ISO CYP26A1 (Homo sapiens) 6480464 tetrabromobisphenol A results in decreased expression of CYP26A1 mRNA CTD PMID:33476716 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP26A1 mRNA CTD PMID:23358152 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CYP26A1 mRNA CTD PMID:25380136 4,4'-diaminodiphenylmethane increases expression ISO Cyp26a1 (Mus musculus) 6480464 4 and 4'-diaminodiphenylmethane results in increased expression of CYP26A1 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO Cyp26a1 (Mus musculus) 6480464 bisphenol S results in increased expression of CYP26A1 mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol increases methylation ISO Cyp26a1 (Mus musculus) 6480464 bisphenol S results in increased methylation of CYP26A1 promoter CTD PMID:33297965 4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine increases expression ISO Cyp26a1 (Mus musculus) 6480464 fenpropimorph results in increased expression of CYP26A1 mRNA CTD PMID:34737147 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 Ro 41-5253 inhibits the reaction [Am 580 results in increased expression of CYP26A1 mRNA] CTD PMID:10953040 4-\{[(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)carbonyl]amino\}benzoic acid increases expression ISO CYP26A1 (Homo sapiens) 6480464 Am 580 results in increased expression of CYP26A1 mRNA CTD PMID:10953040 4-hydroxyphenyl retinamide increases expression ISO CYP26A1 (Homo sapiens) 6480464 Fenretinide results in increased expression of CYP26A1 mRNA CTD PMID:15291358 4-hydroxyphenyl retinamide increases expression ISO Cyp26a1 (Mus musculus) 6480464 Fenretinide results in increased expression of CYP26A1 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO CYP26A1 (Homo sapiens) 6480464 Decitabine affects the expression of CYP26A1 mRNA CTD PMID:23300844 6-bromoindirubin-3'-oxime multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Valproic Acid co-treated with 6-bromoindirubin-3'-oxime] affects the expression of CYP26A1 mRNA CTD PMID:27693483 6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 6-chloro-2 more ... CTD PMID:29990529 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of CYP26A1 mRNA CTD PMID:24780913 9-cis-retinoic acid increases expression ISO Cyp26a1 (Mus musculus) 6480464 Alitretinoin results in increased expression of CYP26A1 mRNA CTD PMID:16688765 9-cis-retinoic acid increases expression ISO CYP26A1 (Homo sapiens) 6480464 Alitretinoin results in increased expression of CYP26A1 mRNA CTD PMID:16194896 and PMID:36805303 acetamide increases expression EXP 6480464 acetamide results in increased expression of CYP26A1 mRNA CTD PMID:31881176 aflatoxin B1 increases expression ISO CYP26A1 (Homo sapiens) 6480464 Aflatoxin B1 results in increased expression of CYP26A1 mRNA CTD PMID:21641981 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CYP26A1 mRNA CTD PMID:33354967 aldrin increases expression ISO CYP26A1 (Homo sapiens) 6480464 Aldrin results in increased expression of CYP26A1 mRNA CTD PMID:15589975 aldrin multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 AGN 193109 inhibits the reaction [Aldrin results in increased expression of CYP26A1 mRNA] CTD PMID:15589975 all-trans-4-hydroxyretinoic acid multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [[Ketoconazole results in decreased activity of CYP26A1 protein] which results in decreased metabolism of Tretinoin] which results in decreased chemical synthesis of 4-hydroxyretinoic acid more ... CTD PMID:12091498 and PMID:25492813 all-trans-4-hydroxyretinoic acid increases expression ISO CYP26A1 (Homo sapiens) 6480464 4-hydroxyretinoic acid results in increased expression of CYP26A1 mRNA CTD PMID:25492813 all-trans-4-hydroxyretinoic acid increases metabolic processing ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 protein results in increased metabolism of 4-hydroxyretinoic acid CTD PMID:25492813 all-trans-4-hydroxyretinoic acid increases chemical synthesis ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 mRNA results in increased chemical synthesis of 4-hydroxyretinoic acid and CYP26A1 protein results in increased chemical synthesis of 4-hydroxyretinoic acid CTD PMID:12091498 more ... all-trans-4-oxoretinoic acid increases chemical synthesis ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 mRNA results in increased chemical synthesis of 4-oxoretinoic acid and CYP26A1 protein results in increased chemical synthesis of 4-oxoretinoic acid CTD PMID:12091498 more ... all-trans-4-oxoretinoic acid increases expression ISO CYP26A1 (Homo sapiens) 6480464 4-oxoretinoic acid results in increased expression of CYP26A1 mRNA CTD PMID:25492813 all-trans-4-oxoretinoic acid increases metabolic processing ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 mRNA results in increased metabolism of 4-oxoretinoic acid and CYP26A1 protein results in increased metabolism of 4-oxoretinoic acid CTD PMID:12091498 and PMID:25492813 all-trans-4-oxoretinoic acid multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [[Ketoconazole results in decreased activity of CYP26A1 protein] which results in decreased metabolism of Tretinoin] which results in decreased chemical synthesis of 4-oxoretinoic acid more ... CTD PMID:12091498 and PMID:25492813 all-trans-4-oxoretinol affects chemical synthesis ISO Cyp26a1 (Mus musculus) 6480464 CYP26A1 protein affects the chemical synthesis of 4-oxoretinol CTD PMID:10557354 all-trans-retinal multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [Retinaldehyde co-treated with Dihydrotestosterone] results in increased expression of CYP26A1 mRNA CTD PMID:17526768 all-trans-retinal increases expression ISO CYP26A1 (Homo sapiens) 6480464 Retinaldehyde results in increased expression of CYP26A1 mRNA CTD PMID:17526768 all-trans-retinoic acid increases expression ISO Cyp26a1 (Mus musculus) 6480464 Tretinoin results in increased expression of CYP26A1 and Tretinoin results in increased expression of CYP26A1 mRNA CTD PMID:10862743 more ... all-trans-retinoic acid increases expression ISO CYP26A1 (Homo sapiens) 6480464 Tretinoin metabolite results in increased expression of CYP26A1 mRNA and Tretinoin results in increased expression of CYP26A1 mRNA CTD PMID:10953040 more ... all-trans-retinoic acid decreases abundance ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 protein results in decreased abundance of Tretinoin CTD PMID:18059332 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of CYP26A1 mRNA CTD PMID:17185629 more ... all-trans-retinoic acid increases metabolic processing ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 mRNA results in increased metabolism of Tretinoin more ... CTD PMID:12091498 more ... all-trans-retinoic acid increases metabolic processing ISO Cyp26a1 (Mus musculus) 6480464 CYP26A1 protein results in increased metabolism of Tretinoin CTD PMID:19010342 all-trans-retinoic acid increases degradation ISO Cyp26a1 (Mus musculus) 6480464 CYP26A1 protein results in increased degradation of Tretinoin CTD PMID:12588859 all-trans-retinoic acid decreases response to substance ISO Cyp26a1 (Mus musculus) 6480464 CYP26A1 protein results in decreased susceptibility to Tretinoin CTD PMID:12588859 all-trans-retinoic acid affects degradation ISO Cyp26a1 (Mus musculus) 6480464 CYP26A1 protein affects the degradation of Tretinoin CTD PMID:16688765 all-trans-retinoic acid multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [DHRS3 gene mutant form results in increased abundance of Tretinoin] which results in increased expression of CYP26A1 mRNA more ... CTD PMID:12588859 more ... all-trans-retinoic acid multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 2 more ... CTD PMID:12091498 more ... all-trans-retinoic acid decreases metabolic processing ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 exon SNP results in decreased metabolism of Tretinoin and CYP26A1 protein polymorphism results in decreased metabolism of Tretinoin CTD PMID:17460545 all-trans-retinoic acid multiple interactions EXP 6480464 [R 115866 results in decreased activity of CYP26A1 protein] which results in increased abundance of Tretinoin and Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:17185629 and PMID:17510468 all-trans-retinol multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [Vitamin A co-treated with RARA protein co-treated with RXRA protein] results in increased expression of CYP26A1 mRNA CTD PMID:17244623 all-trans-retinol increases expression ISO Cyp26a1 (Mus musculus) 6480464 Vitamin A results in increased expression of CYP26A1 mRNA CTD PMID:30944279 all-trans-retinol increases expression ISO CYP26A1 (Homo sapiens) 6480464 Vitamin A results in increased expression of CYP26A1 mRNA CTD PMID:16194896 and PMID:22542753 all-trans-retinol multiple interactions EXP 6480464 [R 115866 co-treated with Vitamin A] results in increased expression of CYP26A1 mRNA CTD PMID:17510468 all-trans-retinol affects metabolic processing ISO Cyp26a1 (Mus musculus) 6480464 CYP26A1 protein affects the metabolism of Vitamin A CTD PMID:10557354 amiodarone increases expression ISO CYP26A1 (Homo sapiens) 6480464 Amiodarone results in increased expression of CYP26A1 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CYP26A1 mRNA CTD PMID:16483693 aphidicolin increases expression ISO Cyp26a1 (Mus musculus) 6480464 Aphidicolin results in increased expression of CYP26A1 mRNA CTD PMID:29990529 arotinoid acid multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 AGN 193109 inhibits the reaction [4-(2-(5 more ... CTD PMID:15589975 arotinoid acid increases expression ISO CYP26A1 (Homo sapiens) 6480464 4-(2-(5 more ... CTD PMID:15589975 arsane multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 Arsenic affects the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:18288313 arsenic atom multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 Arsenic affects the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:18288313 arsenous acid multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:15688020 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of CYP26A1 mRNA CTD PMID:36841081 belinostat increases expression ISO CYP26A1 (Homo sapiens) 6480464 belinostat results in increased expression of CYP26A1 mRNA CTD PMID:26272509 Benoxacor decreases expression ISO Cyp26a1 (Mus musculus) 6480464 benoxacor results in decreased expression of CYP26A1 mRNA CTD PMID:34850242 benzo[a]pyrene decreases expression EXP 6480464 Benzo(a)pyrene results in decreased expression of CYP26A1 mRNA CTD PMID:21839799 benzo[a]pyrene affects methylation ISO CYP26A1 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CYP26A1 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Cyp26a1 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CYP26A1 mRNA CTD PMID:32417428 beta-carotene increases expression ISO CYP26A1 (Homo sapiens) 6480464 beta Carotene results in increased expression of CYP26A1 mRNA CTD PMID:16186334 and PMID:22542753 beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP26A1 mRNA CTD PMID:18164116 bexarotene increases expression ISO CYP26A1 (Homo sapiens) 6480464 bexarotene results in increased expression of CYP26A1 mRNA CTD PMID:17178900 bexarotene multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of CYP26A1 mRNA CTD PMID:17630414 bictegravir increases expression ISO Cyp26a1 (Mus musculus) 6480464 bictegravir results in increased expression of CYP26A1 mRNA CTD PMID:34515794 bis(2-ethylhexyl) phthalate increases expression ISO Cyp26a1 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CYP26A1 mRNA CTD PMID:19245819 bis(2-ethylhexyl) phthalate decreases expression ISO CYP26A1 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in decreased expression of CYP26A1 mRNA CTD PMID:31163220 bis(2-ethylhexyl) phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CYP26A1 promoter CTD PMID:23359474 bisphenol A multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CYP26A1 promoter CTD PMID:23359474 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CYP26A1 mRNA CTD PMID:32145629 bisphenol A increases expression ISO Cyp26a1 (Mus musculus) 6480464 bisphenol A results in increased expression of CYP26A1 mRNA CTD PMID:30951980 more ... bisphenol A decreases expression ISO Cyp26a1 (Mus musculus) 6480464 bisphenol A results in decreased expression of CYP26A1 mRNA CTD PMID:31288075 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CYP26A1 mRNA CTD PMID:25181051 bisphenol A decreases expression ISO CYP26A1 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CYP26A1 mRNA CTD PMID:33476716 Bisphenol B affects expression ISO Cyp26a1 (Mus musculus) 6480464 bisphenol B affects the expression of CYP26A1 mRNA CTD PMID:36881955 Bisphenol B increases expression ISO Cyp26a1 (Mus musculus) 6480464 bisphenol B results in increased expression of CYP26A1 mRNA CTD PMID:36881955 bisphenol F decreases expression ISO CYP26A1 (Homo sapiens) 6480464 bisphenol F results in decreased expression of CYP26A1 mRNA CTD PMID:33476716 bisphenol F increases expression ISO Cyp26a1 (Mus musculus) 6480464 bisphenol F results in increased expression of CYP26A1 mRNA CTD PMID:30951980 bromobenzene increases expression EXP 6480464 bromobenzene results in increased expression of CYP26A1 mRNA CTD PMID:32479839 butanal increases expression ISO CYP26A1 (Homo sapiens) 6480464 butyraldehyde results in increased expression of CYP26A1 mRNA CTD PMID:26079696 cadmium atom decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Cadmium results in decreased expression of CYP26A1 mRNA CTD PMID:19556237 calciol increases expression ISO Cyp26a1 (Mus musculus) 6480464 Cholecalciferol results in increased expression of CYP26A1 mRNA CTD PMID:17170073 calcitriol increases expression ISO CYP26A1 (Homo sapiens) 6480464 Calcitriol results in increased expression of CYP26A1 mRNA CTD PMID:27107558 carbamazepine affects expression ISO CYP26A1 (Homo sapiens) 6480464 Carbamazepine affects the expression of CYP26A1 mRNA CTD PMID:25979313 carbon nanotube decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25620056 choline multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP26A1 mRNA CTD PMID:33549593 ciguatoxin CTX1B affects expression ISO Cyp26a1 (Mus musculus) 6480464 Ciguatoxins affects the expression of CYP26A1 mRNA CTD PMID:18353800 ciprofibrate decreases expression ISO Cyp26a1 (Mus musculus) 6480464 ciprofibrate results in decreased expression of CYP26A1 mRNA CTD PMID:12771043 cisplatin affects expression ISO CYP26A1 (Homo sapiens) 6480464 Cisplatin affects the expression of CYP26A1 mRNA CTD PMID:23300844 cisplatin decreases response to substance ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 protein results in decreased susceptibility to Cisplatin CTD PMID:15703382 clofibrate decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Clofibrate results in decreased expression of CYP26A1 mRNA CTD PMID:17585979 cocaine affects expression EXP 6480464 Cocaine affects the expression of CYP26A1 mRNA CTD PMID:20187946 cyanocob(III)alamin multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP26A1 mRNA CTD PMID:33549593 cyclosporin A increases expression ISO CYP26A1 (Homo sapiens) 6480464 Cyclosporine results in increased expression of CYP26A1 mRNA CTD PMID:33631201 cyproconazole increases expression EXP 6480464 cyproconazole results in increased expression of CYP26A1 mRNA CTD PMID:22664269 dexamethasone decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Dexamethasone results in decreased expression of CYP26A1 mRNA CTD PMID:34464682 diarsenic trioxide multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 Arsenic Trioxide inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:15688020 dibutyl phthalate multiple interactions EXP 6480464 [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of CYP26A1 promoter CTD PMID:23359474 diclofenac decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Diclofenac results in decreased expression of CYP26A1 mRNA CTD PMID:26934552 dieldrin multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 AGN 193109 inhibits the reaction [Dieldrin results in increased expression of CYP26A1 mRNA] CTD PMID:15589975 dieldrin increases expression ISO CYP26A1 (Homo sapiens) 6480464 Dieldrin results in increased expression of CYP26A1 mRNA CTD PMID:15589975 diethylstilbestrol increases expression ISO CYP26A1 (Homo sapiens) 6480464 Diethylstilbestrol results in increased expression of CYP26A1 mRNA CTD PMID:32088792 diethylstilbestrol decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Diethylstilbestrol results in decreased expression of CYP26A1 mRNA CTD PMID:29990529 dolutegravir increases expression ISO Cyp26a1 (Mus musculus) 6480464 dolutegravir results in increased expression of CYP26A1 mRNA CTD PMID:34515794 dolutegravir decreases expression ISO CYP26A1 (Homo sapiens) 6480464 dolutegravir results in decreased expression of CYP26A1 mRNA CTD PMID:34515794 dorsomorphin multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 endosulfan multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 AGN 193109 inhibits the reaction [Endosulfan results in increased expression of CYP26A1 mRNA] CTD PMID:15589975 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CYP26A1 mRNA CTD PMID:29391264 endosulfan increases expression ISO CYP26A1 (Homo sapiens) 6480464 Endosulfan results in increased expression of CYP26A1 mRNA CTD PMID:15589975 and PMID:26615145 endrin increases expression ISO CYP26A1 (Homo sapiens) 6480464 Endrin results in increased expression of CYP26A1 mRNA CTD PMID:15589975 endrin multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 AGN 193109 inhibits the reaction [Endrin results in increased expression of CYP26A1 mRNA] CTD PMID:15589975 entinostat increases expression ISO CYP26A1 (Homo sapiens) 6480464 entinostat results in increased expression of CYP26A1 mRNA CTD PMID:26272509 entinostat multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP26A1 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO Cyp26a1 (Mus musculus) 6480464 epoxiconazole results in decreased expression of CYP26A1 mRNA CTD PMID:35436446 ethanol increases expression ISO Cyp26a1 (Mus musculus) 6480464 Ethanol results in increased expression of CYP26A1 mRNA CTD PMID:19167417 etoposide decreases response to substance ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 protein results in decreased susceptibility to Etoposide CTD PMID:15703382 fenarimol increases expression EXP 6480464 fenarimol results in increased expression of CYP26A1 mRNA CTD PMID:28970091 fenpropidin increases expression ISO Cyp26a1 (Mus musculus) 6480464 fenpropidine results in increased expression of CYP26A1 mRNA CTD PMID:34737147 fipronil increases expression ISO CYP26A1 (Homo sapiens) 6480464 fipronil results in increased expression of CYP26A1 mRNA CTD PMID:27091632 fipronil multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP26A1 mRNA CTD PMID:27091632 fluconazole increases expression ISO Cyp26a1 (Mus musculus) 6480464 Fluconazole results in increased expression of CYP26A1 mRNA CTD PMID:19429397 flusilazole increases expression EXP 6480464 flusilazole results in increased expression of CYP26A1 mRNA CTD PMID:22664269 more ... folic acid multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP26A1 mRNA CTD PMID:33549593 fonofos increases methylation ISO CYP26A1 (Homo sapiens) 6480464 Fonofos results in increased methylation of CYP26A1 promoter CTD PMID:22847954 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CYP26A1 mRNA CTD PMID:33387578 glycine betaine multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP26A1 mRNA CTD PMID:33549593 Heptachlor epoxide increases expression ISO Cyp26a1 (Mus musculus) 6480464 Heptachlor Epoxide results in increased expression of CYP26A1 mRNA CTD PMID:25270620 hexadecanoic acid multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CYP26A1 mRNA and [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26A1 mRNA CTD PMID:30547786 hydrogen peroxide multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 protein inhibits the reaction [[Tretinoin co-treated with Hydrogen Peroxide] results in increased expression of CDKN1A protein] more ... CTD PMID:15703382 hydrogen peroxide decreases response to substance ISO CYP26A1 (Homo sapiens) 6480464 CYP26A1 protein results in decreased susceptibility to Hydrogen Peroxide CTD PMID:15703382 hydroxyurea increases expression ISO Cyp26a1 (Mus musculus) 6480464 Hydroxyurea results in increased expression of CYP26A1 mRNA CTD PMID:29990529 iron dichloride decreases expression ISO CYP26A1 (Homo sapiens) 6480464 ferrous chloride results in decreased expression of CYP26A1 mRNA CTD PMID:35984750 isotretinoin increases expression ISO CYP26A1 (Homo sapiens) 6480464 Isotretinoin results in increased expression of CYP26A1 mRNA CTD PMID:16194896 more ... ketoconazole multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [[Ketoconazole results in decreased activity of CYP26A1 protein] which results in decreased metabolism of Tretinoin] which results in decreased chemical synthesis of 4-hydroxyretinoic acid more ... CTD PMID:12091498 more ... ketoconazole increases expression EXP 6480464 Ketoconazole results in increased expression of CYP26A1 mRNA CTD PMID:28263823 and PMID:37077353 ketoconazole decreases response to substance ISO CYP26A1 (Homo sapiens) 6480464 Ketoconazole results in decreased susceptibility to CYP26A1 protein CTD PMID:18059332 ketoconazole decreases activity ISO CYP26A1 (Homo sapiens) 6480464 Ketoconazole results in decreased activity of CYP26A1 and Ketoconazole results in decreased activity of CYP26A1 protein CTD PMID:14532297 and PMID:25492813 L-methionine multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP26A1 mRNA CTD PMID:33549593 liarozole multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [liarozole co-treated with Tretinoin] results in increased expression of CYP26A1 mRNA and liarozole promotes the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:21428449 and PMID:21838328 liarozole decreases activity ISO CYP26A1 (Homo sapiens) 6480464 liarozole results in decreased activity of CYP26A1 protein CTD PMID:15597402 and PMID:16279770 lipopolysaccharide multiple interactions EXP 6480464 Lipopolysaccharides inhibits the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:17185629 lithocholic acid multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 Lithocholic Acid promotes the reaction [Tretinoin results in increased expression of CYP26A1 mRNA] CTD PMID:18059332 lithocholic acid increases expression ISO CYP26A1 (Homo sapiens) 6480464 Lithocholic Acid results in increased expression of CYP26A1 mRNA CTD PMID:18059332 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP26A1 mRNA CTD PMID:23358152 methoxyacetic acid affects expression ISO Cyp26a1 (Mus musculus) 6480464 methoxyacetic acid affects the expression of CYP26A1 mRNA CTD PMID:32496642 methylmercury chloride affects expression EXP 6480464 methylmercuric chloride affects the expression of CYP26A1 mRNA CTD PMID:20864626 methylmercury chloride increases expression ISO CYP26A1 (Homo sapiens) 6480464 methylmercuric chloride results in increased expression of CYP26A1 mRNA CTD PMID:23179753 more ... microcystin-LR decreases expression ISO Cyp26a1 (Mus musculus) 6480464 cyanoginosin LR results in decreased expression of CYP26A1 mRNA CTD PMID:17383702 mono(2-ethylhexyl) phthalate multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [mono-(2-ethylhexyl)phthalate co-treated with Tretinoin] results in increased expression of CYP26A1 mRNA CTD PMID:36189433 Monobutylphthalate affects expression ISO Cyp26a1 (Mus musculus) 6480464 monobutyl phthalate affects the expression of CYP26A1 mRNA CTD PMID:19162170 Muraglitazar increases expression EXP 6480464 muraglitazar results in increased expression of CYP26A1 mRNA CTD PMID:21515302 N,N-diethyl-m-toluamide multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [fipronil co-treated with DEET] results in increased expression of CYP26A1 mRNA CTD PMID:27091632 N-benzyloxycarbonyl-L-leucyl-L-leucyl-L-leucinal decreases expression ISO CYP26A1 (Homo sapiens) 6480464 benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of CYP26A1 mRNA CTD PMID:31806706 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CYP26A1 mRNA CTD PMID:18164116 N-nitrosodiethylamine decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Diethylnitrosamine results in decreased expression of CYP26A1 mRNA CTD PMID:12771043 and PMID:24535843 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CYP26A1 mRNA CTD PMID:25380136 nicotine decreases expression ISO CYP26A1 (Homo sapiens) 6480464 Nicotine results in decreased expression of CYP26A1 mRNA and Nicotine results in decreased expression of CYP26A1 protein CTD PMID:21371177 Nonylphenol increases expression ISO Cyp26a1 (Mus musculus) 6480464 nonylphenol results in increased expression of CYP26A1 mRNA CTD PMID:31288075 oleic acid multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [Palmitic Acid co-treated with Oleic Acid co-treated with TNF protein] results in increased expression of CYP26A1 mRNA and [Palmitic Acid co-treated with Oleic Acid] results in increased expression of CYP26A1 mRNA CTD PMID:30547786 paracetamol affects expression ISO Cyp26a1 (Mus musculus) 6480464 Acetaminophen affects the expression of CYP26A1 mRNA CTD PMID:17562736 paracetamol decreases expression ISO CYP26A1 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of CYP26A1 mRNA CTD PMID:21420995 parathion increases methylation ISO CYP26A1 (Homo sapiens) 6480464 Parathion results in increased methylation of CYP26A1 promoter CTD PMID:22847954 pentanal increases expression ISO CYP26A1 (Homo sapiens) 6480464 pentanal results in increased expression of CYP26A1 mRNA CTD PMID:26079696 perfluorooctane-1-sulfonic acid multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CYP26A1 mRNA CTD PMID:36331819 phenobarbital increases expression ISO Cyp26a1 (Mus musculus) 6480464 Phenobarbital results in increased expression of CYP26A1 mRNA CTD PMID:19270015 more ... phenobarbital multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP26A1 mRNA CTD PMID:33549593 phenylmercury acetate multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of CYP26A1 mRNA CTD PMID:27188386 piperonyl butoxide increases expression ISO Cyp26a1 (Mus musculus) 6480464 Piperonyl Butoxide results in increased expression of CYP26A1 mRNA CTD PMID:30572783 pirinixic acid multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CYP26A1 mRNA CTD PMID:19710929 pirinixic acid decreases expression ISO Cyp26a1 (Mus musculus) 6480464 pirinixic acid results in decreased expression of CYP26A1 mRNA CTD PMID:23811191 potassium dichromate decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of CYP26A1 mRNA CTD PMID:23608068 pregnenolone 16alpha-carbonitrile increases expression ISO Cyp26a1 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of CYP26A1 mRNA CTD PMID:28903501 progesterone multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [Estradiol co-treated with Progesterone] results in increased expression of CYP26A1 mRNA and [Progesterone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA CTD PMID:17404688 and PMID:20660070 progesterone affects expression ISO Cyp26a1 (Mus musculus) 6480464 Progesterone affects the expression of CYP26A1 mRNA CTD PMID:17251523 progesterone multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Progesterone results in increased activity of PGR protein] which results in increased expression of CYP26A1 mRNA CTD PMID:15845616 progesterone increases expression ISO CYP26A1 (Homo sapiens) 6480464 Progesterone results in increased expression of CYP26A1 mRNA CTD PMID:17404688 promegestone increases expression ISO Cyp26a1 (Mus musculus) 6480464 Promegestone results in increased expression of CYP26A1 mRNA CTD PMID:16955405 promegestone multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Promegestone co-treated with Estradiol] results in increased expression of CYP26A1 mRNA CTD PMID:16955405 propanal increases expression ISO CYP26A1 (Homo sapiens) 6480464 propionaldehyde results in increased expression of CYP26A1 mRNA CTD PMID:26079696 propiconazole increases expression ISO Cyp26a1 (Mus musculus) 6480464 propiconazole results in increased expression of CYP26A1 mRNA CTD PMID:21278054 propiconazole increases expression EXP 6480464 propiconazole results in increased expression of CYP26A1 mRNA CTD PMID:28970091 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of CYP26A1 mRNA CTD PMID:23358152 raloxifene decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Raloxifene Hydrochloride results in decreased expression of CYP26A1 mRNA CTD PMID:29990529 resveratrol multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP26A1 mRNA CTD PMID:25905778 resveratrol multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CYP26A1 mRNA CTD PMID:23557933 resveratrol multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 6-chloro-2 more ... CTD PMID:29990529 and PMID:31298478 resveratrol increases expression ISO Cyp26a1 (Mus musculus) 6480464 Resveratrol results in increased expression of CYP26A1 mRNA CTD PMID:29990529 retinyl acetate multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [retinol acetate co-treated with 2 more ... CTD PMID:16322074 and PMID:31449830 retinyl acetate increases expression ISO Cyp26a1 (Mus musculus) 6480464 retinol acetate results in increased expression of CYP26A1 mRNA CTD PMID:16322074 and PMID:31449830 riddelliine increases expression EXP 6480464 riddelliine results in increased expression of CYP26A1 mRNA CTD PMID:18047727 rifampicin multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [Rifampin co-treated with NR1I2 protein] results in increased expression of CYP26A1 mRNA CTD PMID:21127053 Ro 41-5253 multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 Ro 41-5253 inhibits the reaction [4-(5 more ... CTD PMID:10953040 SB 431542 multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 silicon dioxide increases expression ISO CYP26A1 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of CYP26A1 mRNA CTD PMID:25895662 sodium arsenite increases methylation ISO Cyp26a1 (Mus musculus) 6480464 sodium arsenite results in increased methylation of CYP26A1 gene CTD PMID:24118411 sodium arsenite affects expression ISO CYP26A1 (Homo sapiens) 6480464 sodium arsenite affects the expression of CYP26A1 mRNA CTD PMID:34032870 sodium arsenite increases expression ISO CYP26A1 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CYP26A1 mRNA CTD PMID:28595984 sodium arsenite multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Dietary Fats co-treated with sodium arsenite] results in decreased expression of CYP26A1 mRNA CTD PMID:28283972 sodium arsenite decreases expression ISO Cyp26a1 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CYP26A1 mRNA CTD PMID:28283972 spiroxamine increases expression ISO Cyp26a1 (Mus musculus) 6480464 spiroxamine results in increased expression of CYP26A1 mRNA CTD PMID:34737147 streptozocin multiple interactions EXP 6480464 [resveratrol co-treated with Streptozocin] results in increased expression of CYP26A1 mRNA CTD PMID:25905778 tamoxifen affects expression ISO CYP26A1 (Homo sapiens) 6480464 Tamoxifen affects the expression of CYP26A1 mRNA CTD PMID:14699072 tamoxifen multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in increased expression of CYP26A1 mRNA CTD PMID:17630414 tamoxifen affects expression ISO Cyp26a1 (Mus musculus) 6480464 Tamoxifen affects the expression of CYP26A1 mRNA CTD PMID:20937368 tebuconazole increases expression EXP 6480464 tebuconazole results in increased expression of CYP26A1 mRNA CTD PMID:28970091 terbufos increases methylation ISO CYP26A1 (Homo sapiens) 6480464 terbufos results in increased methylation of CYP26A1 promoter CTD PMID:22847954 Tesaglitazar increases expression EXP 6480464 tesaglitazar results in increased expression of CYP26A1 mRNA CTD PMID:21515302 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in decreased expression of CYP26A1 mRNA CTD PMID:32741896 tetrachloromethane decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Carbon Tetrachloride results in decreased expression of CYP26A1 mRNA CTD PMID:27339419 tetrachloromethane increases expression ISO Cyp26a1 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CYP26A1 mRNA CTD PMID:31919559 tetrachloromethane decreases expression EXP 6480464 Carbon Tetrachloride results in decreased expression of CYP26A1 mRNA CTD PMID:31150632 tetracycline decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Tetracycline results in decreased expression of CYP26A1 mRNA CTD PMID:16917069 Theaflavin 3,3'-digallate affects expression ISO CYP26A1 (Homo sapiens) 6480464 theaflavin-3 and 3'-digallate affects the expression of CYP26A1 mRNA CTD PMID:34925699 thioacetamide decreases expression EXP 6480464 Thioacetamide results in decreased expression of CYP26A1 mRNA CTD PMID:34492290 titanium dioxide decreases expression ISO Cyp26a1 (Mus musculus) 6480464 titanium dioxide results in decreased expression of CYP26A1 mRNA CTD PMID:31298478 titanium dioxide multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 Resveratrol inhibits the reaction [titanium dioxide results in decreased expression of CYP26A1 mRNA] CTD PMID:31298478 triadimefon increases expression ISO Cyp26a1 (Mus musculus) 6480464 triadimefon results in increased expression of CYP26A1 mRNA CTD PMID:19010342 triadimefon increases expression EXP 6480464 triadimefon results in increased expression of CYP26A1 mRNA CTD PMID:22664269 and PMID:28263823 tributylstannane increases expression ISO Cyp26a1 (Mus musculus) 6480464 tributyltin results in increased expression of CYP26A1 mRNA CTD PMID:31939706 trichloroethene decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Trichloroethylene results in decreased expression of CYP26A1 mRNA CTD PMID:25055964 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CYP26A1 mRNA CTD PMID:33387578 trichostatin A decreases expression ISO CYP26A1 (Homo sapiens) 6480464 trichostatin A results in decreased expression of CYP26A1 mRNA CTD PMID:24935251 trichostatin A increases expression ISO CYP26A1 (Homo sapiens) 6480464 trichostatin A results in increased expression of CYP26A1 mRNA CTD PMID:24935251 Triptolide affects expression ISO Cyp26a1 (Mus musculus) 6480464 triptolide affects the expression of CYP26A1 mRNA CTD PMID:32835833 triptonide increases expression ISO Cyp26a1 (Mus musculus) 6480464 triptonide results in increased expression of CYP26A1 mRNA CTD PMID:33045310 troglitazone increases expression EXP 6480464 troglitazone results in increased expression of CYP26A1 mRNA CTD PMID:21515302 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of CYP26A1 mRNA CTD PMID:15885361 valproic acid decreases expression ISO Cyp26a1 (Mus musculus) 6480464 Valproic Acid results in decreased expression of CYP26A1 mRNA CTD PMID:19136453 more ... valproic acid increases methylation ISO CYP26A1 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of CYP26A1 gene CTD PMID:29501571 valproic acid multiple interactions ISO CYP26A1 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of CYP26A1 mRNA CTD PMID:27188386 valproic acid increases expression ISO CYP26A1 (Homo sapiens) 6480464 Valproic Acid results in increased expression of CYP26A1 mRNA CTD PMID:26272509 valproic acid affects expression ISO CYP26A1 (Homo sapiens) 6480464 Valproic Acid affects the expression of CYP26A1 mRNA CTD PMID:25979313 valproic acid multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 4-(2-(5 more ... CTD PMID:27693483 valproic acid affects expression ISO Cyp26a1 (Mus musculus) 6480464 Valproic Acid affects the expression of CYP26A1 mRNA CTD PMID:27693483 valproic acid decreases expression ISO CYP26A1 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of CYP26A1 mRNA CTD PMID:23179753 more ... vorinostat decreases expression ISO CYP26A1 (Homo sapiens) 6480464 vorinostat results in decreased expression of CYP26A1 mRNA CTD PMID:27188386 zinc atom multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP26A1 mRNA CTD PMID:33549593 zinc(0) multiple interactions ISO Cyp26a1 (Mus musculus) 6480464 [Methionine co-treated with Choline co-treated with Folic Acid co-treated with Betaine co-treated with Vitamin B 12 co-treated with Zinc co-treated with Phenobarbital] results in increased expression of CYP26A1 mRNA CTD PMID:33549593